Skip to main content

Table 2 Comparison of clinical and laboratory findings between groups at hospital admission

From: Erythromycin versus neomycin in the treatment of hepatic encephalopathy in cirrhosis: a randomized double-blind study

Initial variables Erythromycin Neomycin p
Episodic HE1 4 7 0.449
Persistent HE1 11 7 0.263
Non classified HE1 0 1 0.992
Age (years) 2 55.20 ± 13.51 58.80 ± 10.47 0.421
Child-Pugh score 3 8.00 (8.00 : 10.50) 9.00 (8.00 : 10.75) 0.421
MELD score 2 16.40 ± 3.89 15.22 ± 4.40 0.440
HEG (grades) 3 2.00 (1.00 : 2.75) 2.00 (1.00 : 3.00) 0.421
HEI 3 13.00 (10.00 : 16.50) 14.00 (9.00 : 18.00) 0.588
GCS 3 14.00 (13.00 : 14.00) 13.00 (10.25 : 14.75) 0.394
CRP 3 0.80 (0.35 : 2.325) 1.40 (0.50 : 3.80) 0.475
NH3 3 96.00 (80.75 : 118.50) 82.00 (45.50 : 174.75) 0.468
  1. Child-Pugh score = Child-Pugh modified classification. HEG = hepatic encephalopathy grades. HEI = hepatic encephalopathy index. GCS = Glasgow coma scale. CRP = C reactive protein (mg/dl). NH3 = serum ammonia (μM/l). 1 absolute values and Z score comparison; 2 mean ± standard deviation and t test comparison ; 3 median, 1º : 3º quartiles and Mann–Whitney test comparison.